| Pharmacological Effects of Natural Compounds | Lifetime | 26 | CN 5 | 99.54 |
| Natural product bioactivities and synthesis | Lifetime | 85 | CN 15 | 99.36 |
| Traditional Chinese Medicine Analysis | Lifetime | 42 | CN 35 | 99.14 |
| Traditional Chinese Medicine and Integrative Care | Lifetime | 37 | CN 28 | 97.02 |
| Ubiquitin and proteasome pathways | Lifetime | 238 | CN 16 | 98.80 |
| Ginseng Biological Effects and Applications | Lifetime | 73 | CN 38 | 98.28 |
| Cancer-related molecular mechanisms research | Lifetime | 603 | CN 264 | 98.24 |
| Phytochemistry and Biological Activities | Lifetime | 244 | CN 38 | 98.47 |
| Traditional Chinese Medicine Studies | Lifetime | 110 | CN 78 | 96.94 |
| Bioactive Compounds and Antitumor Agents | Lifetime | 188 | CN 8 | 97.66 |
| Medicinal Plants and Bioactive Compounds | Lifetime | 48 | CN 11 | 95.97 |
| Cancer-related Molecular Pathways | Lifetime | 621 | CN 26 | 97.91 |
| Medicinal Plants and Neuroprotection | Lifetime | 152 | CN 11 | 96.62 |
| Cancer Mechanisms and Therapy | Lifetime | 336 | CN 48 | 96.54 |
| Cell death mechanisms and regulation | Lifetime | 428 | CN 28 | 96.98 |
| Cytokine Signaling Pathways and Interactions | Lifetime | 706 | CN 40 | 96.56 |
| Histone Deacetylase Inhibitors Research | Lifetime | 572 | CN 54 | 95.10 |
| Healthcare and Venom Research | Lifetime | 723 | CN 114 | 92.38 |
| Natural Compound Pharmacology Studies | Lifetime | 165 | CN 28 | 92.65 |
| Acupuncture Treatment Research Studies | Lifetime | 614 | CN 221 | 92.30 |
| Biological Activity of Diterpenoids and Biflavonoids | Lifetime | 366 | CN 60 | 92.42 |
| Phytochemistry and biological activity of medicinal plants | Lifetime | 200 | CN 39 | 90.92 |
| Flavonoids in Medical Research | Lifetime | 264 | CN 104 | 88.74 |
| Hedgehog Signaling Pathway Studies | Lifetime | 943 | CN 30 | 90.01 |
| Protein Tyrosine Phosphatases | Lifetime | 647 | CN 50 | 89.08 |
| Phytochemical and Pharmacological Studies | Lifetime | 250 | CN 36 | 86.36 |
| Medicinal Plant Pharmacodynamics Research | Lifetime | 311 | CN 203 | 83.47 |
| Plant-based Medicinal Research | Lifetime | 903 | CN 255 | 87.69 |
| Medicinal plant effects and applications | Lifetime | 364 | CN 48 | 86.00 |
| Phytochemistry and Bioactive Compounds | Lifetime | 637 | CN 120 | 86.26 |
| Synthesis and bioactivity of alkaloids | Lifetime | 343 | CN 35 | 84.47 |
| Bioactive natural compounds | Lifetime | 777 | CN 161 | 83.73 |
| Berberine and alkaloids research | Lifetime | 844 | CN 297 | 80.28 |
| FOXO transcription factor regulation | Lifetime | 673 | CN 138 | 79.05 |
| Hydrogen's biological and therapeutic effects | Lifetime | 724 | CN 217 | 74.66 |
| Natural Compounds in Disease Treatment | Lifetime | 666 | CN 341 | 68.52 |
| Pharmacological Effects of Medicinal Plants | Lifetime | 958 | CN 85 | 63.47 |
| Morinda citrifolia extract uses | Lifetime | 903 | CN 119 | 61.84 |
| Antioxidants, Aging, Portulaca oleracea | Lifetime | 290 | CN 120 | 59.80 |
| Pharmacological Effects of Natural Compounds | 2021-2025 | 5 | CN 2 | 99.07 |
| Traditional Chinese Medicine Analysis | 2021-2025 | 11 | CN 9 | 98.59 |
| Natural product bioactivities and synthesis | 2021-2025 | 36 | CN 20 | 97.55 |
| Cancer Mechanisms and Therapy | 2021-2025 | 39 | CN 12 | 96.76 |
| Cancer-related molecular mechanisms research | 2021-2025 | 438 | CN 334 | 96.46 |
| Cancer-related Molecular Pathways | 2021-2025 | 73 | CN 10 | 94.81 |
| Immune cells in cancer | 2021-2025 | 267 | CN 149 | 94.83 |
| Bioactive Compounds and Antitumor Agents | 2021-2025 | 51 | CN 2 | 92.98 |
| Cancer, Hypoxia, and Metabolism | 2021-2025 | 400 | CN 168 | 91.74 |
| RNA modifications and cancer | 2021-2025 | 993 | CN 681 | 93.47 |
| Phytochemistry and Biological Activities | 2021-2025 | 211 | CN 38 | 92.46 |
| Ubiquitin and proteasome pathways | 2021-2025 | 272 | CN 122 | 91.13 |
| Cytokine Signaling Pathways and Interactions | 2021-2025 | 167 | CN 36 | 87.10 |
| Ginseng Biological Effects and Applications | 2021-2025 | 152 | CN 131 | 88.73 |
| Cell death mechanisms and regulation | 2021-2025 | 90 | CN 21 | 85.40 |
| Plant-based Medicinal Research | 2021-2025 | 74 | CN 55 | 82.83 |
| Reproductive System and Pregnancy | 2021-2025 | 902 | CN 285 | 83.81 |
| Flavonoids in Medical Research | 2021-2025 | 70 | CN 17 | 77.85 |
| FOXO transcription factor regulation | 2021-2025 | 75 | CN 19 | 71.16 |
| Synthesis of Organic Compounds | 2021-2025 | 182 | CN 63 | 75.13 |
| PI3K/AKT/mTOR signaling in cancer | 2021-2025 | 476 | CN 103 | 71.00 |
| Natural Compound Pharmacology Studies | 2021-2025 | 161 | CN 64 | 68.76 |
| Medicinal Plants and Bioactive Compounds | 2021-2025 | 441 | CN 191 | 55.38 |
| Retinoids in leukemia and cellular processes | 2021-2025 | 970 | CN 255 | 48.87 |
| Phosphodiesterase function and regulation | 2021-2025 | 560 | CN 106 | 31.66 |
